{
  "name": "Zara Al-Rashid",
  "email": null,
  "phone": null,
  "location": "Mumbai, India",
  "linkedin": null,
  "objective": null,
  "education": [
    {
      "degree": "PGDM",
      "major": "Finance",
      "school": "Indian School of Business Management (ISBM), Pune",
      "start": "Jan-01-2012",
      "end": "Jan-01-2014",
      "honors": null
    },
    {
      "degree": "M.B.B.S",
      "major": null,
      "school": "K.J. Somaiya Medical College, Mumbai",
      "start": "Jan-01-2005",
      "end": "Jan-01-2010",
      "honors": null
    },
    {
      "degree": "XII Std.",
      "major": null,
      "school": "Mithibai College, Mumbai",
      "start": "Jan-01-2003",
      "end": "Jan-01-2004",
      "honors": null
    },
    {
      "degree": "X Std.",
      "major": null,
      "school": "St. Xavier's High School, Mumbai",
      "start": "Jan-01-2001",
      "end": "Jan-01-2002",
      "honors": null
    }
  ],
  "experiences": [
    {
      "company": "Meridian Research Partners",
      "title": "Lead Analyst – Pharmaceuticals and Healthcare",
      "start": "May-01-2022",
      "end": null,
      "sectors": [
        "Healthcare"
      ],
      "approach": "Fundamental",
      "client_type": "Buy-side",
      "num_companies_covered": 28,
      "num_sectors_covered": null,
      "coverage_value": null,
      "regions_covered": [
        "Asia-Pacific"
      ],
      "sharpe_ratio": null,
      "alpha": null,
      "valuation_methods_used": null,
      "quant_tools_used": null,
      "bullet_points": [
        "Generate investment ideas and publish equity research ratings with price targets on Indian healthcare sector companies across 28 stocks under coverage"
      ]
    },
    {
      "company": "Prism Financial Services",
      "title": "Lead Analyst – Pharmaceuticals and Healthcare",
      "start": "Oct-01-2020",
      "end": "Apr-30-2022",
      "sectors": [
        "Healthcare"
      ],
      "approach": "Fundamental",
      "client_type": "Buy-side",
      "num_companies_covered": null,
      "num_sectors_covered": null,
      "coverage_value": null,
      "regions_covered": [
        "Asia-Pacific"
      ],
      "sharpe_ratio": null,
      "alpha": null,
      "valuation_methods_used": null,
      "quant_tools_used": null,
      "bullet_points": [
        "Voted by top domestic institutional investors: Axis Mutual Fund, SBI Mutual Fund, Nippon Life Asset Management, ICICI Prudential MF, Aditya Birla Sun Life MF, Reliance MF, LIC MF, Mirae Asset MF, Invesco MF, and Sundaram MF",
        "Investment recommendation adopted by major institutional client resulting in 35% increase in brokerage commission revenue"
      ]
    },
    {
      "company": "Kotak Securities",
      "title": "Lead Analyst – Pharmaceuticals and Healthcare",
      "start": "Apr-01-2018",
      "end": "Apr-30-2020",
      "sectors": [
        "Healthcare"
      ],
      "approach": "Fundamental",
      "client_type": "Buy-side",
      "num_companies_covered": null,
      "num_sectors_covered": null,
      "coverage_value": null,
      "regions_covered": [
        "Asia-Pacific"
      ],
      "sharpe_ratio": null,
      "alpha": null,
      "valuation_methods_used": null,
      "quant_tools_used": null,
      "bullet_points": [
        "Published sector thematic reports on Indian generics expansion, digital health initiatives, respiratory drug market, and healthcare policy reforms",
        "Hosted Organized healthcare policy conference in Mumbai covering regulatory changes, generic drug policies, and government health initiatives with key policymakers"
      ]
    },
    {
      "company": "DataFlow Research India Pvt. Limited, Noida",
      "title": "Manager – Equity Research",
      "start": "May-01-2015",
      "end": "Mar-31-2018",
      "sectors": [
        "Healthcare"
      ],
      "approach": "Fundamental",
      "client_type": "Buy-side",
      "num_companies_covered": null,
      "num_sectors_covered": null,
      "coverage_value": null,
      "regions_covered": [
        "Asia-Pacific"
      ],
      "sharpe_ratio": null,
      "alpha": null,
      "valuation_methods_used": null,
      "quant_tools_used": null,
      "bullet_points": [
        "Member, U.S. Healthcare Services ER team (Institutional Investor (II) Runner up) at Leerink Partners",
        "Awarded \"Excellence in Research\" recognition for superior analytical work and report quality (2015)"
      ]
    },
    {
      "company": "J.P. Morgan Securities, London",
      "title": "Equity Research Associate",
      "start": "Sep-01-2013",
      "end": "Dec-31-2013",
      "sectors": null,
      "approach": null,
      "client_type": null,
      "num_companies_covered": null,
      "num_sectors_covered": null,
      "coverage_value": null,
      "regions_covered": [
        "Europe"
      ],
      "sharpe_ratio": null,
      "alpha": null,
      "valuation_methods_used": null,
      "quant_tools_used": null,
      "bullet_points": [
        "Assist in team transition during replacement of a research associate and to work closely with the team",
        "Attended meetings & calls with company IRs, institutional investors, & industry experts",
        "Attended a company investor day at LSE and prepared a key takeaways note for publication"
      ]
    },
    {
      "company": "Cipla Pharmaceuticals, Mumbai",
      "title": "Summer Intern",
      "start": "Apr-01-2011",
      "end": "May-31-2011",
      "sectors": null,
      "approach": null,
      "client_type": null,
      "num_companies_covered": null,
      "num_sectors_covered": null,
      "coverage_value": null,
      "regions_covered": [
        "Asia-Pacific"
      ],
      "sharpe_ratio": null,
      "alpha": null,
      "valuation_methods_used": null,
      "quant_tools_used": null,
      "bullet_points": [
        "Project scope Competitive Positioning strategy for newly launched generic Calpol T using MDS (Perceptual Mapping)",
        "Formulated competitive positioning strategy & communication tactics as a result of which Calpol T Key achievements had overtaken more than 90 brands in same category and is currently holding the 2nd rank",
        "Scored 99.92 percentile in Quantitative Aptitude in CAT-2009",
        "Consistent score of over 95% in Mathematics through XII Std."
      ]
    }
  ],
  "skills": [
    "MS Office",
    "Bloomberg",
    "Factset",
    "Reuters",
    "FDA",
    "MedPAC",
    "CMS",
    "WHO",
    "German DRG",
    "USRDS",
    "PubMed"
  ],
  "certifications": [],
  "languages": [],
  "primary_sector": "Healthcare",
  "primary_strategy": "Fundamental",
  "primary_geography": "Asia-Pacific",
  "current_level": "Director",
  "years_experience": 8
}